MC4R rs489693: A clinical risk factor for second generation antipsychotic-related weight gain?

International Journal of Neuropsychopharmacology

Volumn 16, Issue 9, 2013, Pages 2103-2109

  Czerwensky, Fabian ^a   Leucht, Stefan ^b   Steimer, Werner ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antipsychotic therapy; human melanocortin four receptor gene (MC4R); pharmacogenetic; weight gain

Indexed keywords

AMISULPRIDE; CLOZAPINE; MELANOCORTIN 4 RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE;

ADULT; ADVERSE OUTCOME; ALLELE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT GAIN;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 4; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; WEIGHT GAIN;

EID: 84883355708     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713000849     Document Type: Article

References (19)

1. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156:1686-1696
2. Czerwensky F, Leucht S, Steimer W (2013) Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain. J Clin Psychopharmacol 33:74-79
3. Drieling T, Biedermann NC, Scharer LO, Strobl N, Langosch JM (2007) Psychotropic drug-induced change of weight: a review. Fortschr Neurol Psychiatr 75:65-80
4. Fan ZC, Tao YX (2009) Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients. J Cell Mol Med 13:3268-3282
5. Frayling TM, Ong K (2011) Piecing together the FTO jigsaw. Genome Biol 12:104.
6. Frayling TM et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889-894
7. Hugenholtz GW, Heerdink ER, Meijer WE, Stolker JJ, Egberts AC, Nolen WA (2005) Reasons for switching between antipsychotics in daily clinical practice. Pharmacopsychiatry 38:122-124
8. Kane JM, Leucht S, Carpenter D, Docherty JP (2003) The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry 64(Suppl. 12):5-19
9. Kinon BJ, Kaiser CJ, Ahmed S, Rotelli MD, Kollack-Walker S (2005) Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders. J Clin Psychopharmacol 25:255-258
10. Kurzthaler I, Fleischhacker WW (2001) The clinical implications of weight gain in schizophrenia. J Clin Psychiatry 62(Suppl. 7):32-37
11. Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Muller DJ (2011) Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry 17:242-266
12. Lipkovich I, Jacobson JG, Hardy TA, Hoffmann VP (2008) Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder. BMC Psychiatry 8:78.
13. Loos RJ et al. (2008) Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 40:768-775
14. Malhotra AK, Correll CU, Chowdhury NI, Muller DJ, Gregersen PK, Lee AT, Tiwari AK, Kane JM, Fleischhacker WW, Kahn RS, Ophoff RA, Meltzer HY, Lencz T, Kennedy JL (2012) Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Arch Gen Psychiatry 69:904-912
15. Newcomer JW (2007) Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 68(Suppl. 1):20-27
16. Popp J, Messner B, Steimer W (2003) High-speed genotyping of CYP1A2 1F mutation with fluorescent hybridization probes using the LightCycler. Pharmacogenomics 4:643-646
17. Tao YX (2005) Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol Cell Endocrinol 239:1-14
18. Weiden PJ, Mackell JA, McDonnell DD (2004) Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 66:51-57
19. Xi B, Chandak GR, Shen Y, Wang Q, Zhou D (2012) Association between common polymorphism near the MC4R gene and obesity risk: a systematic review and meta-Analysis. PLoS ONE 7:e45731. doi: 10.1371/journal. pone.0045731.